Alison Bertuch
Pediatric Hematology-Oncology · Houston, TXNPI 1285714600
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,467 of the $1,467 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Biomarin Pharmaceutical Inc..
Across 1 payment — averaging $1467.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$1K
Across 12 payments — averaging $151,746 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$1.8M
- National Marrow Donor Program$13K
What the payments were for
- Speaking & faculty fees$1,467100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 1 | $1,467 |
How this compares
$1,467 in reported general payments places this provider in the 65th percentile of 235 pediatric hematology-oncology providers in Texas.
Other pediatric hematology-oncology in Houston
- Vivek SubbiahHouston$194K
- Clay CohenHouston$62K
- Jenny DespotovicHouston$59K
- Helen HeslopHouston$51K
- Nidra RodriguezHouston$48K
- Venee TubmanHouston$43K
- Youngna Lee KimHouston$36K
- Richard GorlickHouston$21K
- Carl AllenHouston$18K
- Titilope FasipeHouston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.